October 15, 2020   Sweden
Nordiclifescience.org: Recruitment drive underway at Diamyd Medical
With the setup of a completely new facility within a highly technical and regulated industry, Johansson and her colleagues are paving the way for the development for future precision medicine treatments of type 1 diabetes.

“Having a well controlled and scalable process is key to succeeding long term with the drug development and commercialization. By making sure this is integrated in the company, we gain control and are less dependent on external factors and therefore less vulnerable to disruptive events”, says Maja Johansson, Site Manager in Umeå.

Read the article
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research